ClinicalTrials.gg
CompletedNCT06578845HappyMumsUpdated Nov 3, 2026

HappyMums Mobile Application Study

An observational study in Pregnancy and Antenatal Depression, sponsored by King's College London. Completed at 7 sites in 6 countries. Open to female participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-11-03.

Sponsored by King's College London · Observational

How we know

Updated Nov 3, 2026Now CompletedPrimary completion moved+1 moreGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Case-only
Time perspective
Prospective
Enrollment
1,020
Ages
18 Years and older
Sex
Female
01

Where this study stands

Counted across the records on this site · 2026-11-21

Among 32 studies in Depression by King's College London — 5 open to participants now, 8 under way, none of them phase 3. Depression · King's College London.

Started
2025
with 1 other
Observational
7 of 32
3 open now
Registered
26th of 32
by date

Among the 32 studies in Depression by King's College London, this one is one of 2 that started in 2025, is one of 7 observational ones, and was the 26th registered.

Depression

8,608 studies on the registry are indexed under Depression; 1,736 are open to participants now.

Browse Depression studies →

Open to participants now

5 of the 32 studies in Depression by King's College London are open now, in 1 country. Recruiting first, the newest first:

By country, each count listing its studies:

All 5 open studies →

Who these studies take

Of the 1,098 Depression studies recruiting now, 475 (43%) set no upper age limit and 522 (48%) stop at 75 or younger; 205 take children under 18; 315 take healthy volunteers.

This study: 18 Years and older · female · healthy volunteers too.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 32 studies in Depression by King's College London, or all of them as a file.
02

Study summary

The goal of this study is to investigate whether pregnant people at risk of, or currently suffering from antenatal depression, find it acceptable to use the 'HappyMums' mobile application during their pregnancy. This app will collect data relevant to their mental health passively and through active engagement from the user. After the study is complete, these data will be put together to determine if such data types could be used in future to help predict and identify antenatal depression, and aid better treatment decisions.

Read the detailed description

HappyMums aims to develop a digital platform (smartphone app), and investigate whether data collected by a mobile app can be used to help learn more about mental health symptoms in pregnant women and birthing people at risk of depression in pregnancy.

This study aims to investigate the acceptability and usability of the HappyMums App. Following data collection, data will be aggregated to generate statistical models, with the aim of testing their predictive ability for antenatal depression trajectories.

The application will collect and integrate heterogenous data and will also allow an improvement of lifestyle attitudes, the maintenance of wellbeing in pregnancy, and the continuous monitoring of treatment efficacy. HM will therefore contribute to reducing the stigma by empowering mothers and birthing parents to monitor and master their mental health.

The study objective is to actively and passively gather data relevant to perinatal mental health, via a mobile application, which will be used to retrospectively develop an algorithm capable of identifying mental health trajectories in at-risk women/birthing people. The app will include game-like activities, access to an antenatal wellbeing course and space for pregnancy- and health-related data logging and monitoring. It will also utilise smartphone sensors to collect passive data types such as GPS, phone usage and step counts. This study will test the use of such mobile applications for patient mental health monitoring, and will also collect traditional research data such as biological samples and standardised questionnaires to be used as comparators to app-derived data.

Participants: Participants will be pregnant people either currently experiencing depressive symptoms, or who meet criteria for at least one risk factor for antenatal depression, previously identified from the literature, such as pregnancy complications or lack of social support. They will be recruited from 13 weeks' gestation to 28 weeks' gestation.

Recruitment: Recruitment will be conducted through self-referral, social media and online advertisement, and poster/flyer advertising in spaces and publications relevant to pregnant people, such as antenatal and health clinics, antenatal education spaces, children and family centres and newsletters.

Measures and Outcomes: Models will be generated to determine the ability of passively and actively app-collected data to predict antenatal depression symptoms through pregnancy, and how this compares to traditional measures such as standardised mental health questionnaires: Edinburgh Postnatal Depression Scale (EPDS), Generalised Anxiety Disorder Assessment (GAD-7) and Patient Health Questionnaire (PHQ-9).

For further cohort characterisation and to determine the influence of risk factors, other measures will also be collected and tested in the model: Mini International Neuropsychiatric Interview (subset only), Childhood Trauma Questionnaire (subset only), Adult Attachment Questionnaire, Life Events, Composite Abuse Scale, Maternal Antenatal Attachment Scale (subset only), Perceived Stress Scale (subset only), Multidimensional Scale of Perceived Social Support (subset only), Couple Satisfaction Index (subset only) and Postpartum Bonding Questionnaire (subset only).

03

Conditions studied

  • Pregnancy
  • Antenatal Depression

Browse trials for

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
Female
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

The study will consist of pregnant participants, up to 28 weeks' gestation, who have at least one risk factor for antenatal depression, or current depressive symptoms.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Pregnant people, aged 18 or older and up to 28 weeks' gestation.
  • Satisfactory understanding of English/national language of host country, in order to give fully .
  • Either suffering with depressive symptoms currently, or who have at least one risk factor for antenatal depression.
  • Owning a smartphone capable of downloading and running HappyMums application

Exclusion criteria

Exclusion Criteria:

  • Inability to give .
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Observational model
Case-only
Time perspective
Prospective
Enrollment
1,020 participants (actual)
Patient registry
No

Groups and cohorts

  • Pregnant people currently experiencing, or at risk of, antenatal depression

    All eligible participants will be given access to the 'HappyMums' mobile application, which will be used to collect data pertinent to their mental health status during pregnancy.

06

What researchers measure

Primary outcomes

  1. Proportion of participants who continue to use mobile application from enrolment until they give birth.

    The primary outcome is whether participants feel able to continue to use the app throughout their pregnancy. Usage data of the app will be logged to ascertain if participants continue to engage with it throughout their pregnancy. 'Usage' of the application will be defined as submission of any questionnaire, logging of data, or interaction with any other activities or content on the application. This will be quantified as proportion of participants who use the app weekly from their enrolment on the app to the end of their pregnancy.

    Time frame: From enrolment to end of pregnancy.

Secondary outcomes

  1. Usability of the mobile application - System Usability Scale

    Questionnaire given to participants after pregnancy to ascertain if they find the app system usable.

    Time frame: Administered once - to be completed from delivery to 2 months postpartum.

  2. Acceptance of the mobile application - Unified Theory of Acceptance and Use of Technology Scale.

    Questionnaire given to participants after pregnancy to ascertain if they find the app system acceptable.

    Time frame: Administered once - to be completed from delivery to 2 months postpartum.

  3. Severity of antenatal depression - Edinburgh Postnatal Depression Scale

    Antenatal depression will be measured using the EPDS, and will be available to complete on the application every 2 weeks.

    Time frame: Every 2 weeks from enrolment to end of pregnancy.

  4. Development of clinically significant depression - Mini International Neuropsychiatric Interview

    The MINI will be administered to a validation sub-cohort to identify development of, or change in, symptoms of Major Depressive Disorder. This will be used to validate app-derived data types used to identify depression.

    Time frame: Administered at enrolment and up to 2 months postpartum

07

Study locations

7 sites
  • Catholic University of Croatia
    Zagreb, Croatia
  • University of Helsinki
    Helsinki, Finland
  • Charité - Universitätsmedizin Berlin
    Berlin, Germany
  • San Raffaele Hospital
    Milan, Italy
  • University of Milan
    Milan, Italy
  • SWPS University
    Warsaw, Poland
  • King's College London
    London, UK SE5 9RX, United Kingdom
08

References and documents

Publications

  • Priestley K, Laijawala R, Hazelgrove K, Bind R, Rebecchini L, Mariani N, Alford S, Kirkpatrick M, Mancino F, Kim S, Pushpakanthan S, Biaggi A, Cavaliere L, Di Benedetto MG, Matijas M, Zutic M, Brekalo M, Nakic Rados S, Zukowska K, Braniecka A, Jackowska M, Bessi M, Agnoletto E, Melloni EMT, Benedetti F, Bulgheroni M, La Gamba M, Martin Isla C, Izquierdo Morcillo C, Lekadir K, Salo V, Seikku T, Raikkonen K, Godara M, Schneider-Schmid UM, Entringer S, Buss C, de Barra D, Woods A, Dazzan P, Cattaneo A, Pariante C. HappyMums mobile application study protocol: use of a smartphone application to gather data predictive of antenatal depression. BMJ Open. 2026 Feb 4;16(2):e106978. doi: 10.1136/bmjopen-2025-106978. PubMed 41638734 ↗

Individual participant data

Plan to share: No

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedDate before it movedWhere the date was before it movedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Feb 2025 to primary completion in Oct 2026, 20 months.

Of 463 non-industry observational studies under Depression, half reached primary completion within 33 months of starting (the median), counting those still running; a quarter within 14 and three quarters within 63. This study's 20 months is below that.

Counting every sponsor, half of 496 studies reached it within 32 months; a quarter within 13 and three quarters within 61.

Primary completion moved once since we started tracking on Sep 25, 2026: Jul 2026 → Oct 2026, on Nov 3, 2026.

Earlier changes are on the record history on ClinicalTrials.gov ↗

How these figures are worked out, and which studies are left out of them.

Registered
May 28, 2024
First posted
Aug 29, 2024
StartActual
Feb 18, 2025
Primary completionActual
Oct 31, 2026was Jul 2026
CompletionActual
Oct 31, 2026
Last update
Nov 3, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Status
Recruiting→Completed
changed Nov 3, 2026
Primary completion
Jul 30, 2026→Oct 31, 2026 (actual)
Nov 3, 2026
Enrollment
1000 (estimated)→1020 (actual)
Nov 3, 2026
Show all 1 update
  1. Nov 3, 2026
    Recruiting→Completed
    Primary completion Jul 30, 2026→Oct 31, 2026 (now actual)
    Enrollment 1000 (estimated)→1020 (actual)
    + 3 other changes: verification date, contact details and site details

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT06578845
Collaborators
University of Milan, Ospedale San Raffaele, Catholic University of Croatia, University of Helsinki, Charite University, Berlin, Germany, SWPS University of Social Sciences and Humanities, Ab.Acus, University of Barcelona
Responsible party
Sponsor
First posted
Aug 29, 2024
Start date
Feb 18, 2025
Primary completion
Oct 31, 2026
Completion
Oct 31, 2026
Last update
Nov 3, 2026

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion